Evidence map›Paper›PMID 26490709›Full record

ArticleScientific reports2015

Aberrant Autophagic Response in The Muscle of A Knock-in Mouse Model of Spinal and Bulbar Muscular Atrophy.

Paola Rusmini, Maria Josefa Polanco, Riccardo Cristofani, Maria Elena Cicardi, Marco Meroni, Mariarita Galbiati, Margherita Piccolella, Elio Messi, Elisa Giorgetti, Andrew P Lieberman and 6 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 53 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Bicalutamide and Trehalose Ameliorate Spinal and Bulbar Muscular Atrophy Pathology in Mice.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2023
    Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 2 countries.

Paola RusminiDipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Centro di Eccellenza sulle Malattie Neurodegenerative, Università degli Studi di Milano, Milano, Italy.
Maria Josefa PolancoDulbecco Telethon Institute, Centre for Integrative Biology (CIBIO), Università degli Studi di Trento, Trento, Italy.
Riccardo CristofaniDipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Centro di Eccellenza sulle Malattie Neurodegenerative, Università degli Studi di Milano, Milano, Italy.
Maria Elena CicardiDipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Centro di Eccellenza sulle Malattie Neurodegenerative, Università degli Studi di Milano, Milano, Italy.
Marco MeroniDipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Centro di Eccellenza sulle Malattie Neurodegenerative, Università degli Studi di Milano, Milano, Italy.
Mariarita GalbiatiDipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Centro di Eccellenza sulle Malattie Neurodegenerative, Università degli Studi di Milano, Milano, Italy.
Margherita PiccolellaDipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Centro di Eccellenza sulle Malattie Neurodegenerative, Università degli Studi di Milano, Milano, Italy.
Elio MessiDipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Centro di Eccellenza sulle Malattie Neurodegenerative, Università degli Studi di Milano, Milano, Italy.
Elisa GiorgettiDepartment of Pathology, University of Michigan, Ann Arbor, Michigan, USA.
Andrew P LiebermanDepartment of Pathology, University of Michigan, Ann Arbor, Michigan, USA.
Carmelo MiliotoDulbecco Telethon Institute, Centre for Integrative Biology (CIBIO), Università degli Studi di Trento, Trento, Italy.
Anna RocchiNeuroscience and Brain Technologies Department, Istituto Italiano di Tecnologia, Genova, Italy.
Tanya AggarwalNeuroscience and Brain Technologies Department, Istituto Italiano di Tecnologia, Genova, Italy.
Maria PennutoDulbecco Telethon Institute, Centre for Integrative Biology (CIBIO), Università degli Studi di Trento, Trento, Italy.
Valeria CrippaLaboratory of Experimental Neurobiology, C. Mondino National Neurological Institute, Pavia, Italy.
Angelo PolettiDipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Centro di Eccellenza sulle Malattie Neurodegenerative, Università degli Studi di Milano, Milano, Italy.
University of Florence · ITUniversity of Milan · ITDulbecco Telethon Institute · ITItalian Institute of Technology · ITUniversity of Michigan–Ann Arbor · USFondazione Istituto Neurologico Nazionale Casimiro Mondino · ITUniversity of Trento · IT

Funding

Mechanisms of motor neuron toxicity in Kennedy DiseaseR01NS055746 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LIEBERMAN, ANDREW P, OSAWA, YOICHI · 2007 to 2021
$6.0M
NINDS NIH HHS R01 NS055746Telethon GGP14039Telethon TCP12013
6 · The paper itself

Abstract

Spinal and bulbar muscular atrophy (SBMA) is characterized by loss of motoneurons and sensory neurons, accompanied by atrophy of muscle cells. SBMA is due to an androgen receptor containing a polyglutamine tract (ARpolyQ) that misfolds and aggregates, thereby perturbing the protein quality control (PQC) system. Using SBMA AR113Q mice we analyzed proteotoxic stress-induced alterations of HSPB8-mediated PQC machinery promoting clearance of misfolded proteins by autophagy. In muscle of symptomatic AR113Q male mice, we found expression upregulation of Pax-7, myogenin, E2-ubiquitin ligase UBE2Q1 and acetylcholine receptor (AchR), but not of MyoD, and of two E3-ligases (MuRF-1 and Cullin3). TGFβ1 and PGC-1α were also robustly upregulated. We also found a dramatic perturbation of the autophagic response, with upregulation of most autophagic markers (Beclin-1, ATG10, p62/SQSTM1, LC3) and of the HSPB8-mediated PQC response. Both HSPB8 and its co-chaperone BAG3 were robustly upregulated together with other specific HSPB8 interactors (HSPB2 and HSPB3). Notably, the BAG3:BAG1 ratio increased in muscle suggesting preferential misfolded proteins routing to autophagy rather than to proteasome. Thus, mutant ARpolyQ induces a potent autophagic response in muscle cells. Alteration in HSPB8-based PQC machinery may represent muscle-specific biomarkers useful to assess SBMA progression in mice and patients in response to pharmacological treatments.

Indexed as

AnimalsAutophagyDisease Models, AnimalGene Expression RegulationGene Knock-In TechniquesHSP27 Heat-Shock ProteinsHumansMiceMuscular Disorders, AtrophicProtein FoldingReceptors, AndrogenUbiquitinUbiquitin-Protein LigasesAR protein, humanHSP27 Heat-Shock ProteinsHSPB2 protein, humanReceptors, AndrogenUbiquitinUbiquitin-Protein Ligases

Identifiers

PMID26490709
PMCPMC4614888
OpenAlexW1813423898

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.